Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Hawaii Tech Times.
Press releases published on April 16, 2025

Aurora Mobile Launches Hong Kong Edition of JVerification to Streamline and Innovate Cross-Border Login and Verification
SHENZHEN, China, April 16, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services in China, today announced the official launch of the Hong …

RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME
RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME ISTURISA® is a cortisol synthesis inhibitor that blocks the enzyme 11β-hydroxylase to help normalize …

LearnWorlds hits 500,000 courses milestone, signaling demand for a new generation of elearning platforms
ATHENS, Greece, April 16, 2025 (GLOBE NEWSWIRE) -- LearnWorlds, the elearning platform that combines the power of an LMS with the agility of a modern course builder, has officially surpassed 500,000 courses created by its users. The milestone comes shortly …

Basilea berichtet über Präsentation neuer Daten zu Fosmanogepix, Isavuconazol (Cresemba®) und Ceftobiprol (Zevtera®) auf dem Fachkongress ESCMID Global 2025
Allschwil, 16. April 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren Infektionen durch Bakterien oder Pilze erkrankt sind, gab …

Basilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025
Allschwil, Switzerland, April 16, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today scientific …

Santhera informiert über den kommerziellen Rollout von AGAMREE®
Pratteln, Schweiz, 16. April 2025 - Santhera Pharmaceuticals (SIX: SANN) gibt den neuesten Fortschritt beim kommerziellen Rollout von AGAMREE® zur Behandlung von Duchenne-Muskeldystrophie (DMD) bekannt. Für AGAMREE zur Behandlung von Duchenne- …

Ipsen delivers strong sales in the first quarter 2025 and confirms its full-year guidance
Total sales growth of 11.6% at CER1, or 11.7% as reported, driven by all three therapeutic areas and including an increasing contribution from Iqirvo and Bylvay. Tovorafenib regulatory submission to EMA2 for pediatric low-grade glioma. Confirmation of full …

Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l’exercice 2025
Croissance des ventes de 11,6% à taux de change constant1, ou 11,7% en données publiées, tirée par toutes les aires thérapeutiques, incluant une contribution croissante d'Iqirvo et de Bylvay. Soumission réglementaire à l'EMA2 de tovorafenib pour le gliome …

La subsidiaria ZenaDrone de ZenaTech ofrece una actualización sobre el proceso de certificación Green UAS para el dron IQ Square diseñado para estudios de levantamiento topográfico, inspecciones de puentes y otras aplicaciones de defensa en EE. UU.
VANCOUVER, Columbia Británica, April 15, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), una empresa de tecnología especializada en drones con IA (Inteligencia Artificial), Dron como un Servicio (DaaS), …

Proto Hologram Expands in India with Amitabh Bachchan & Sourav Ganguly
Hyderabad, India, April 15, 2025 (GLOBE NEWSWIRE) -- Proto Hologram has expanded rapidly across India, with the launch of AI Avatars of Amitabh Bachchan and Sourav “Dada” Ganguly. Based on IP deals created by Hyderbad-based company Ikonz, the Proto avatars …